首页 > 市场调查报告书 > 医疗设备

e保健

市场调查报告书

商品编码

1678796

日本远端病患监控市场 - 2025 至 2033 年

Japan Remote Patient Monitoring Market - 2025-2033

出版日期: 2025年03月11日 | 出版商:

DataM Intelligence | 英文 210 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年日本远距病人监护市场规模达到 4.7056 亿美元，预计到 2033 年将达到 35.3654 亿美元，2025-2033 年预测期内的复合年增长率为 24.9%。

远端病人监控 (RPM) 是一种医疗保健实践，它使用数位技术从传统环境之外的患者收集医疗资料，使医生能够即时或定期追踪生命体征。此技术对于患有慢性病的患者、老年人或术后照护者特别有益，因为它可以及时介入并减少就诊次数。 RPM 允许在患者未实际身处医疗机构的情况下进行持续监测，从而加强了对患者的护理，改善了健康状况，并提高了便利性。

市场动态：

驱动因素与约束因素

科技进步和穿戴式装置的普及

日本远距病人监控 (RPM) 市场受到医疗技术进步和穿戴式医疗设备的日益普及的推动。这些设备追踪即时健康参数，提高准确性和效率。它们与智慧型手机应用程式和云端平台相结合，促进主动的患者管理。这项技术进步提高了患者的接受度，并鼓励医疗保健提供者将 RPM 纳入他们的实践中。一般来说，老年人或慢性病患者是远距病人监护设备的目标族群；然而，在日本，一些公司正在提出创新技术来追踪各类患者的健康状况。

例如，日本公司MEDIROM Healthcare technologies Inc.最近推出了创新产品“MOTHER Bracelet”，该产品是一款免充电的智慧健康追踪器，可与远端健康监测系统REMONY集成，从而广受欢迎。 2025年1月，该公司与TOPPAN Inc.的电子部门合作，提供这些先进的监控设备。 TOPPAN计划利用这些设备（MOTHER Bracelet和REMONY）来监测员工的健康状况，并旨在建立一个能够在出现某些健康异常时儘早发现并迅速应对的环境。

资料隐私和安全问题

由于对资料隐私和安全的担忧，日本远端病人监控 (RPM) 市场面临重大挑战。 RPM 系统收集和传输敏感的患者健康资料，任何违规都可能导致未经授权的存取。严格的资料保护法规和对安全漏洞的担忧阻碍了患者和医疗保健提供者全面采用 RPM 解决方案，从而阻碍了市场成长。

Remote Patient Monitoring (RPM) is a healthcare practice that uses digital technologies to collect medical data from patients outside traditional settings, enabling doctors to track vital signs in real time or periodically. This technology is particularly beneficial for patients with chronic conditions, elderly individuals, or post-operative care, as it allows timely interventions and reduces hospital visits. RPM enhances patient care, improves health outcomes, and promotes convenience by allowing continuous monitoring without physically present patients in a healthcare facility.

Market Dynamics: Drivers & Restraints

Technological Advancements and Increasing Adoption of Wearable Devices

The Japan remote patient monitoring (RPM) market is driven by advancements in healthcare technology and the growing use of wearable health devices. These devices track real-time health parameters, improving accuracy and efficiency. They are integrated with smartphone applications and cloud platforms, promoting proactive patient management. This technological evolution has increased patient acceptance and encouraged healthcare providers to incorporate RPM into their practices. Generally, elderly or chronic disease patients are the target population for remote patient monitoring devices; however, in Japan, several companies are coming up with innovations to track the health and wellness of all types of patients.

For instance, a Japan-based company, MEDIROM Healthcare technologies Inc., has recently become popular with the launch of its innovation, the "MOTHER Bracelet", a charging-free smart health tracker that is integrated with REMONY, a remote health monitoring system. In January 2025, the company collaborated with the Electronics Division of TOPPAN Inc. to provide these advanced monitoring devices. TOPPAN plans to use these devices, the MOTHER Bracelet and REMONY, for the health monitoring of its employees and aims to establish an environment that enables early detection and prompt responses in the event of certain health abnormalities.

Data Privacy and Security Concerns

The Japanese remote patient monitoring (RPM) market faces significant challenges due to concerns over data privacy and security. RPM systems collect and transmit sensitive patient health data, and any breach can lead to unauthorized access. Strict data protection regulations and fear of security vulnerabilities discourage patients and healthcare providers from fully adopting RPM solutions, hindering market growth.

Segment Analysis

The Japan remote patient monitoring market is segmented based on device type, application, and end user.

Device Type:

Wearable Devices in the device type segment are expected to dominate with the highest market share.

Japan's remote patient monitoring (RPM) market is thriving due to wearable devices that enable real-time health tracking, early disease detection, and continuous management of chronic conditions. These devices collect vital health data, such as heart rate, blood pressure, oxygen levels, and glucose levels. The integration of AI and IoT in wearable technology improves data analysis, reduces hospital visits, and enhances patient engagement, particularly in Japan's aging population and increasing demand for home-based care. Several innovative wearable devices are being launched in the Japanese market, which can significantly tap the areas with high unmet needs.

For instance, in September 2024, iRhythm Technologies, Inc. announced that the Japanese Pharmaceutical and Medical Device Agency (PMDA) has approved Zio fourteen-day, long-term continuous ECG monitoring system. Zio is a wearable device supported with ZEUS - Zio ECG Utilization Software System and iRhythm's advanced AI algorithm, and can be used in the early diagnosis of cardiac arrhythmias.

Competitive Landscape

The major country players in the remote patient monitoring market include Nihon Kohden Corporation, OMRON Healthcare Co., Ltd Terumo Corporation, Fukuda Denshi Co., Ltd, Panasonic Healthcare Co., Ltd., Sharp Corporation (Healthcare Devices Division), Medirom Healthcare Technologies Inc, A&D Company, Limited, HealthNode, Medical Edge Co Ltd and among others.

Key Developments

In April 2024, OMRON Healthcare Co., Ltd. acquired Luscii Healthtech, a rapidly growing digital health and remote consultation service platform. Since OMRON's seed investment in 2018, the two companies have collaborated on digital health development. Luscii, a pioneer in smart remote care and virtual wards, has a unique culture for innovation and an agile philosophy, enabling them to address the complex demands of healthcare systems.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Country's Growth & Investment: Highlights high-growth countries and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan Remote Patient Monitoring market report delivers a detailed analysis with 72 key tables, more than 67 visually impactful figures, and 210 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Speciality Area & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Device Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Country

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological Advancements and Increasing Adoption of Wearable Devices
- 4.1.2. Restraints
  - 4.1.2.1. Data Privacy and Security Concerns
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Device Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 6.1.2. Market Attractiveness Index, By Device Type
6.2. Wearable Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Non-Wearable Devices

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Chronic Disease Management*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Post-Operative Care
7.4. Maternal Health
7.5. Mental Health
7.6. Emergency Care
7.7. General Health and Wellness
7.8. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Homecare Settings
8.4. Others

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

10.1. Nihon Kohden Corporation*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio
  - 10.1.2.1. Product Description
  - 10.1.2.2. Product Key Performance Indicators (KPIs)
  - 10.1.2.3. Historic and Forecasted Product Sales
  - 10.1.2.4. Product Sales Volume
- 10.1.3. Financial Overview
  - 10.1.3.1. Company Revenue's
  - 10.1.3.2. Geographical Revenue Shares
  - 10.1.3.3. Revenue Forecasts
- 10.1.4. Key Developments
  - 10.1.4.1. Mergers & Acquisitions
  - 10.1.4.2. Key Product Development Activities
  - 10.1.4.3. Regulatory Approvals, etc.
- 10.1.5. SWOT Analysis
10.2. OMRON Healthcare Co., Ltd.
10.3. Terumo Corporation
10.4. Fukuda Denshi Co., Ltd.
10.5. Panasonic Healthcare Co., Ltd.
10.6. Sharp Corporation (Healthcare Devices Division)
10.7. Medirom Healthcare Technologies Inc
10.8. A&D Company, Limited
10.9. HealthNode
10.10. Medical Edge Co Ltd
Similar data will be provided for each market player.